Large-scale testing (Phase 3)Study completedNCT00470522What this trial is testingStudy of Methotrexate in Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus University Health Network, Toronto 86
Not applicableStudy completedNCT04180228What this trial is testingHuman Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases.Who this might be right forSystemic Lupus ErythematosusIdiopathic Juvenile ArthritisHuman Papilloma Virus Hospices Civils de Lyon 76
Not applicableStudy completedNCT00493753What this trial is testingFeasibility and Safety of Acupuncture for Systemic LupusWho this might be right forSystemic Lupus Erythematosus University of Pittsburgh 24
Not applicableStudy completedNCT00544102What this trial is testingInsulin Resistance and Atherosclerosis in Women With LupusWho this might be right forSystemic Lupus ErythematosusInsulin ResistanceAtherosclerosis National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 50
Not applicableStudy completedNCT02769195What this trial is testingUtility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLEWho this might be right forSystemic Lupus Erythematosus Monash University 1,684
Testing effectiveness (Phase 2)Study completedNCT00637819What this trial is testingLeflunomide in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Eythematosus (SLE) Sanofi 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778446What this trial is testingTest CRT-402 in Refractory Autoimmune DiseaseWho this might be right forAutoimmune DiseasesSystemic Lupus ErythematosusSystemic Scleroderma+1 more Myeloid Therapeutics 34
Large-scale testing (Phase 3)Study completedNCT02504645What this trial is testingA 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus ErythematosusWho this might be right forLupus Erythematosus, Systemic ImmuPharma 202
Not applicableUnknownNCT05362812What this trial is testingPrediction of Lupus Renal Flares StudyWho this might be right forSystemic Lupus Erythematosus Charite University, Berlin, Germany 120
Testing effectiveness (Phase 2)Study completedNCT01283139What this trial is testingEvaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus MedImmune LLC 834
Not applicableUnknownNCT04532541What this trial is testingMonogenic Lupus in Childhood Onset Systemic Lupus ErythematosusWho this might be right forMonogenic LupusSystemic Lupus Erythematosus Children's Hospital of Fudan University 200
Testing effectiveness (Phase 2)Ended earlyNCT04680637What this trial is testingEfficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus ErythematosusWho this might be right forActive Systemic Lupus Erythematosus Amgen 168
Early research (Phase 1)Study completedNCT03817424What this trial is testingEvaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisWho this might be right forSystemic Lupus ErythematosusCutaneous Lupus ErythematosusSjogren's Syndrome+3 more Amgen 31
Not applicableUnknownNCT03296995What this trial is testingAccuracy, Feasibility and Acceptance of CGM LupusWho this might be right forSystemic Lupus ErythematosusCritical IllnessDiabetic Blood Glucose Monitoring RenJi Hospital 30
Not applicableEnded earlyNCT02811094What this trial is testingLUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of RelapseWho this might be right forSystemic Lupus Erythematosus (SLE) Assistance Publique Hopitaux De Marseille 210
Early research (Phase 1)Study completedNCT03451422What this trial is testingSafety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Amgen 35
Not applicableStudy completedNCT02988661What this trial is testingWomen Empowered to Live With Lupus StudyWho this might be right forLupus Erythematosus, Systemic Emory University 699
Early research (Phase 1)WithdrawnNCT06984341What this trial is testingEvaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus Genentech, Inc.
Early research (Phase 1)Looking for participantsNCT07115745What this trial is testingHealthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesWho this might be right forRefractory Autoimmune Diseases Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Large-scale testing (Phase 3)Looking for participantsNCT07405970What this trial is testingClinical Study of MIL62 in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Beijing Mabworks Biotech Co., Ltd. 316